ArticleInternational journal of clinical oncology2021

A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer.

Shunji Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.